home / stock / iphyf / iphyf message board
Subject | By | Source | When |
---|---|---|---|
Stock Tracker: Latest Innate Pharma (IPHYF) Headlines INNATE PHARMA : raises 20.3 million in a | Stock_Tracker | investorshangout | 03/10/2014 10:53:12 AM |
chartguy89: IPHYF 15.058 Stock Charts $IPHYF 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 4:38:31 AM |
chartguy89: IPHYF Stock Charts Last: -0.78 Thursday, February 27, 2014 at 3:45:56 AM $IPHYF | chartguy89 | investorshangout | 02/27/2014 8:46:08 AM |
News, Short Squeeze, Breakout and More Instantly...
Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...
SAR443579/IPH6101, ANKET ® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under development by Sanofi in R/R AML, B-ALL and HR-MDS SAR443579/IPH6101 continues ...
In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL...